Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.
about
Localization and functional characterization of the rat Oatp4c1 transporter in an in vitro cell system and rat tissuesExpression and functional features of NaCT, a sodium-coupled citrate transporter, in human and rat livers and cell linesGenetic variation in drug transporters in ethnic populations.Assessment of a candidate marker constituent predictive of a dietary substance-drug interaction: case study with grapefruit juice and CYP3A4 drug substrates.The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.Nuclear receptors CAR and PXR in the regulation of hepatic metabolism.SLCO1B1 521T-->C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patientsHuman Organic Solute Transporter (hOST): protein interaction and membrane sorting process.Membrane transporter proteins: a challenge for CNS drug development.Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions.Transporter-mediated drug interactions: clinical implications and in vitro assessment.Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell lines.Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.Transporter-mediated uptake into cellular compartments.Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestineCompartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid.Dynamic localization of hepatocellular transporters in health and disease.Cultured mammary epithelial monolayers (BME-UV) express functional organic anion and cation transporters.New strategies to deliver anticancer drugs to brain tumors.Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs.Which drug or drug delivery system can change clinical practice for brain tumor therapy?Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system.Physiological and molecular biochemical mechanisms of bile formation.Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.Noninvasive Assessment of Elimination and Retention using CT-FMT and Kinetic Whole-body Modeling.Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.Pharmacokinetic Drug Interactions with Panax ginseng.The expression of efflux and uptake transporters are regulated by statins in Caco-2 and HepG2 cells.Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP.Quantitative Evaluation of Drug Resistance Profile of Cells Expressing Wild-Type or Genetic Polymorphic Variants of the Human ABC Transporter ABCC4.Long-term effects of Panax ginseng on disposition of fexofenadine in rats in vivo.Distribution dynamics and functional importance of NHERF1 in regulation of Mrp-2 trafficking in hepatocytes.Prediction of fraction metabolized via CYP3A in humans utilizing cryopreserved human hepatocytes from a set of 12 single donors.Ezrin regulates the expression of Mrp2/Abcc2 and Mdr1/Abcb1 along the rat small intestinal tract.Fatty Acid Binding Proteins: Potential Chaperones of Cytosolic Drug Transport in the Enterocyte?
P2860
Q28480934-26A6BB68-5D3B-47BB-98A1-4524151A363DQ28582660-13EFD309-630C-493A-A6C6-3906DD4A03DBQ34292537-2063BDEF-236D-4A7D-8B88-31AB6D53491FQ34573885-B357D68D-483A-4D93-872D-03A2167E47F4Q34613443-3AC6950C-D08D-489A-B022-5407F13D9CB9Q35842802-87ED562B-DD77-4DC9-8E84-385D2D5254DDQ36024636-EFA0891C-2620-427A-B6D5-37DE45CE9B3BQ36334254-A1CC2826-3953-4F94-BF3C-7D464136F5BDQ36659167-67BA9E9E-7824-4D11-8125-F97FE4D7D225Q36687277-69B447D3-D531-4A15-BA66-8ECE3325E4A0Q36725218-94EE0C7A-E15B-4203-A5BC-43B6F8F2D825Q36725222-79BC312C-B410-4060-A0C1-A133A13335C6Q36744766-58A6E04C-0740-496C-9398-C203ABC67E97Q36985063-9006DD85-E758-4E42-85D3-8A4D402A1041Q36985076-B06F14C4-5584-44C3-B2E6-8BB993E0DA0AQ37058658-E6123004-897C-42E0-B71F-C2679E0B453DQ37214548-CA8FC1F5-C01D-45FB-BFD1-40A7D1868FA4Q37311185-E1B75EFD-F05C-471F-9CCE-11F6DEF7EA89Q37341910-D37F23DF-08AD-416C-8E35-9F8A908F4707Q37353975-5DD1CAB3-031F-4FA7-B3F3-674CA662BD99Q37364700-9B754666-FBCF-4129-8E51-E378F01AFDE7Q37521059-388ACA84-35BB-4387-B086-58A6FB0330DBQ38090394-6AA7E4BD-0ECA-4670-936A-E2F3D968BE67Q38133554-7B99C8D7-0FC6-458F-B638-A28247445FF7Q38164702-CB1B6778-B910-4D2B-902F-42E47B6CE881Q38613161-931D3F4D-A6D3-437A-9106-E5544B2E8AA3Q38772061-25BB6993-8D2B-48D1-8C2D-9E489E9689F2Q38888350-CDA6AECC-9C72-4026-B5DD-9A5D17A6C70BQ39013824-27676DB9-E12D-46BB-905E-E215321DD217Q39123948-F3BFDE30-1109-4E48-9FB5-D55421335883Q39233839-DA2551D2-4187-4E4F-BDB4-7302C4AF095DQ41182056-9C8221E4-4D9D-41F6-A65C-4F3BE7612800Q43298460-E26B0C20-B1AB-49E4-A430-93FE3B2332E1Q44676651-23449FCD-8EA5-4D87-A664-FD68CBEC1CBDQ47943718-EF15C222-1329-48D3-9002-817A6936CDAEQ54405469-56601A23-91A5-44FD-BC4A-11A777AD7620Q57835970-7643D1E2-E334-46B3-BF99-9BAB9BB195BA
P2860
Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Apical/basolateral surface exp ...... e in vectorial drug transport.
@ast
Apical/basolateral surface exp ...... e in vectorial drug transport.
@en
type
label
Apical/basolateral surface exp ...... e in vectorial drug transport.
@ast
Apical/basolateral surface exp ...... e in vectorial drug transport.
@en
prefLabel
Apical/basolateral surface exp ...... e in vectorial drug transport.
@ast
Apical/basolateral surface exp ...... e in vectorial drug transport.
@en
P2093
P2860
P1476
Apical/basolateral surface exp ...... e in vectorial drug transport.
@en
P2093
Hiroshi Suzuki
Kousei Ito
Toshiharu Horie
Yuichi Sugiyama
P2860
P304
P356
10.1007/S11095-005-6810-2
P577
2005-09-22T00:00:00Z